Clopidogrel Use and CYP2C19 Genotypes in Patients Undergoing Vascular Intervention Procedure: A Hospital-Based Study

Clopidogrel Use and CYP2C19 Genotypes in Patients Undergoing Vascular Intervention Procedure: A Hospital-Based Study

Yi-Ju Liao,1 Tzu-Hung Hsiao,2– 4 Ching-Heng Lin,2,3,5,6 Chun-Sheng Hsu,7– 10 Yen-Lin Chang,1,8 Yu-Wei Chen,11 Chiann-Yi Hsu,2,12 Yi-Ming Chen,2,10,13– 15,* Ming-Fen Wu1,* 1Department of Pharmacy, Taichung Veterans General Hospital, Taichung, Taiwan; 2Department of Medical Research, T...

Full description

Bibliographic Details
Main Authors: Liao YJ, Hsiao TH, Lin CH, Hsu CS, Chang YL, Chen YW, Hsu CY, Chen YM, Wu MF
Format: Article
Language:English
Published: Dove Medical Press 2022-02-01
Series:Pharmacogenomics and Personalized Medicine
Subjects:
pharmacogenomics
clopidogrel
cyp2c19
taiwan precision medicine initiative (tpmi)
carotid intervention
Online Access:https://www.dovepress.com/clopidogrel-use-and-cyp2c19-genotypes-in-patients-undergoing-vascular--peer-reviewed-fulltext-article-PGPM

Internet

https://www.dovepress.com/clopidogrel-use-and-cyp2c19-genotypes-in-patients-undergoing-vascular--peer-reviewed-fulltext-article-PGPM

Similar Items